CTLA4 and type 2 diabetes mellitus: Single‐nucleotide polymorphisms in CTLA‐4 have been correlated with a variety of autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, type 2 diabetes, and rheumatoid arthritis.22, 23, 24, 25